{"cluster": 62, "subcluster": 13, "abstract_summ": "Notably, compared with the active conformation of the apo state structure in pH7.6 of SARS, the SARS-CoV-2 apo state is in the inactive conformation under condition close to physiological state (pH7.5).Here we report the first insight of the structure Mpro for SARS-CoV-2 in the inactive conformation under conditions close to the physiological state (pH 7.5) to an overall resolution of 1.9 \u00c5. The comparisons of Mpro in different states reveal that substrate binding site and the active site are more flexible in the inactive conformation than that in the active conformations.In this paper, we describe a drug repurposing strategy based on a virtual screening of druggable pockets located in the central \u03b2-sheet core of the SARS-CoV-2 Spike protein RBD supported by in vitro tests identifying several steroidal derivatives as SARS-CoV-2 entry inhibitors.Two water molecules are present in the oxyanion hole in our apo state structure, whereas in the ligand-bound structure, water molecular is absence in the same region.All together, these results might help to define novel approaches to reduce the viral load by using SARS-CoV-2 entry inhibitors.", "title_summ": "Hijacking SARS-Cov-2/ACE2 receptor interaction by natural and semi-synthetic steroidal agents acting on functional pockets on receptor binding regionRapid assessment of ligand binding to the SARS-CoV-2 main protease by saturation transfer difference NMR spectroscopyStructure of SARS-CoV-2 main protease in the apo state reveals the inactive conformationTargeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assayStructural plasticity of SARS-CoV-2 3CL M(pro) active site cavity revealed by room temperature X-ray crystallographyAssessment of Proton-Coupled Conformational Dynamics of SARS and MERS Coronavirus Papain-like Proteases: Implication for Designing Broad-Spectrum Antiviral Inhibitors", "title_abstract_phrases": "Structure of SARS-CoV-2 main protease in the apo state reveals the inactive conformationMpro is of considerable interest as a drug target in the treatment of COVID-19 since the proteolytic activity of this viral protease is essential for viral replication.Notably, compared with the active conformation of the apo state structure in pH7.6 of SARS, the SARS-CoV-2 apo state is in the inactive conformation under condition close to physiological state (pH7.5).Here we report the first insight of the structure Mpro for SARS-CoV-2 in the inactive conformation under conditions close to the physiological state (pH 7.5) to an overall resolution of 1.9 \u00c5. The comparisons of Mpro in different states reveal that substrate binding site and the active site are more flexible in the inactive conformation than that in the active conformations.Combined with crystallographic structures of these fragments bound to Mpro, this information can assist ongoing drug design efforts.In this paper, we describe a drug repurposing strategy based on a virtual screening of druggable pockets located in the central \u03b2-sheet core of the SARS-CoV-2 Spike protein RBD supported by in vitro tests identifying several steroidal derivatives as SARS-CoV-2 entry inhibitors."}